Molecules 2012, 17, 9641-9651; doi:10.3390/molecules17089641 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Article Deoxycalyciphylline B, a Hepatotoxic Alkaloid from Daphniphyllum calycinum Xiaopo Zhang 1, Junqing Zhang 1, Yinfeng Tan 1, Qibing Liu 1 and Mingsheng Liu 2,3,* 1 School of Pharmaceutical Science, Hainan Medical University, Haikou 571101, Hainan, China; E-Mails:
[email protected] (X.Z.);
[email protected] (J.Z.);
[email protected] (Y.T.);
[email protected] (Q.L.) 2 Hainan Provincial Institute of South and Li Medicine Development, Haikou 571101, Hainan, China 3 Guangzhou Unversity of Chinese Medicine, Guangzhou 510006, Guangdong, China * Author to whom correspondence should be addressed; E-Mail:
[email protected]; Tel./Fax: +86-898-6689-3826. Received: 2 July 2012; in revised form: 1 August 2012 / Accepted: 7 August 2012 / Published: 13 August 2012 Abstract: Daphniphyllum calycinum (DC), a main component of Chinese patent drug Fengliao-Changweikang, is effectively used to cure bowel disease in the clinic. It was recorded that DC possessed slight toxicity, which was caused by the alkaloids existing in its extract. Unfortunately, to date the toxicity level and toxic constituents are still unclear. The present study is designed to illustrate the acute toxicity and induced organ damages of the total alkaloids as well as to determine the toxic constituents. Based on the above studies, not only was the acute toxicity determined but also hepatic toxicity was characterized by increased plasma biomarkers of ALT and AST and liver cell inflammatory infiltrate as well necrosis that was firstly observed. Significantly, deoxycalyciphylline B exhibited exactly the same hepatic toxicity so it was identified as the main toxic constituent in DC.